Menu
Psoriasis latest research
In support of Psoriasis Awareness Month in August, the editorial team at Dove Medical Press has compiled the latest Psoriasis research as it is published across our journal portfolio. Thank you to all the researchers and peer reviewers who have contributed to this collection of articles.
This content is free to access and updated daily.
- 72 records -
Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies
Heidemeyer K, May Lee M, Cazzaniga S, Yawalkar N, Naldi L
Psoriasis: Targets and Therapy 2023, 13:33-58
Published Date: 22 September 2023
Rehmannioside A Inhibits TRAF6/MAPK Pathway and Improves Psoriasis by Interfering with the Interaction of HaCaT Cells with IL-17A
Yuan LL, Cao CY
Clinical, Cosmetic and Investigational Dermatology 2023, 16:2585-2596
Published Date: 21 September 2023
Cellular Mechanisms of Psoriasis Pathogenesis: A Systemic Review
Wu M, Dai C, Zeng F
Clinical, Cosmetic and Investigational Dermatology 2023, 16:2503-2515
Published Date: 14 September 2023
Fibrinogen is Associated with Clinical Adverse Events in Patients with Psoriasis and Coronary Artery Disease
Zhao L, Zeng Y, Sun L, Zhang Z, Yang K, Li Z, Wang M, Zhou X, Yang W
Journal of Inflammation Research 2023, 16:4019-4030
Published Date: 12 September 2023
Curcumin Alleviates Epidermal Psoriasis-Like Dermatitis and IL-6/STAT3 Pathway of Mice
Cai Z, Zeng Y, Liu Z, Zhu R, Wang W
Clinical, Cosmetic and Investigational Dermatology 2023, 16:2399-2408
Published Date: 1 September 2023
Resveratrol Ameliorates Imiquimod-Induced Psoriasis-Like Mouse Model via Reducing Macrophage Infiltration and Inhibiting Glycolysis
Wang Y, Qi C, Feng F, Hu X, Zhao N, Zhao J, Di T, Meng Y, Yang D, Zhu H, Zhang X, Li P, Wang Y
Journal of Inflammation Research 2023, 16:3823-3836
Published Date: 30 August 2023
Safety of Biologics for Psoriatic Patients with Latent Tuberculosis
Yuan L, Li Y, Lin J, Lin X, Yang B, Man MQ, Wang X
Clinical, Cosmetic and Investigational Dermatology 2023, 16:2333-2336
Published Date: 28 August 2023
Bioinformatics and Systems Biology Approach to Identify the Pathogenetic Link Between Psoriasis and Cardiovascular Disease
Shi L, Du X, Li J, Zhang G
Clinical, Cosmetic and Investigational Dermatology 2023, 16:2283-2295
Published Date: 22 August 2023
Therapeutic Management of a Case of Severe Psoriasis Coexistent with Bullous Pemphigoid in the Elderly
Di Lernia V, Peccerillo F, Ficarelli E
Psoriasis: Targets and Therapy 2023, 13:27-31
Published Date: 22 August 2023
Anxiety and Depression in People with Eczema or Psoriasis: A Comparison of Associations in UK Biobank and Linked Primary Care Data
Matthewman J, Mansfield KE, Hayes JF, Adesanya EI, Smith CH, Roberts A, Langan SM, Henderson AD
Clinical Epidemiology 2023, 15:891-899
Published Date: 7 August 2023
Psoriasis on Lesions of Vitiligo: A Case Report
Wang L, Zhang B
Clinical, Cosmetic and Investigational Dermatology 2023, 16:2005-2007
Published Date: 4 August 2023
Psoriasis and COVID-19 Infection Negatively Impact Each Other: An Analysis of 3581 Cases
Wang X, Yuan L, Qiu X, Yang B, Man MQ
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1933-1936
Published Date: 25 July 2023
Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice
Zhao K, Pu S, Sun L, Zhou D
International Journal of Nanomedicine 2023, 18:3781-3800
Published Date: 10 July 2023
Bimekizumab in the Treatment of Plaque Psoriasis: Focus on Patient Selection and Perspectives
Camiña-Conforto G, Mateu-Arrom L, López-Ferrer A, Puig L
Patient Preference and Adherence 2023, 17:1541-1549
Published Date: 30 June 2023
The Combination of IL-6, PLR and Nail Psoriasis: Screen for the Early Diagnosis of Psoriatic Arthritis
Liu X, Zhao Y, Mu Z, Jia Y, Liu C, Zhang J, Cai L
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1703-1713
Published Date: 28 June 2023
Insulin Stimulates IL-23 Expression in Human Adipocytes: A Possible Explanation for the Higher Prevalence of Psoriasis in Obesity
Di Vincenzo A, Granzotto M, Crescenzi M, Costa C, Piaserico S, Vindigni V, Vettor R, Rossato M
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1885-1893
Published Date: 23 June 2023
Psoriasis and Leprosy: An Arcane Relationship
Ge G, Shang J, Gan T, Chen Z, Pan C, Mei Y, Long S, Wu A, Wang H
Journal of Inflammation Research 2023, 16:2521-2533
Published Date: 14 June 2023
Cutaneous Adverse Events After COVID-19 Vaccination
Weschawalit S, Pongcharoen P, Suthiwartnarueput W, Srivilaithon W, Daorattanachai K, Jongrak P, Chakkavittumrong P
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1473-1484
Published Date: 8 June 2023
Study on the Key Genes and Molecular Mechanisms of IL-27 Promoting Keratinocytes Proliferation Based on Transcriptome Sequencing
Wu Z, Yang Q, Xu K, Wu J, Yang B
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1457-1472
Published Date: 7 June 2023
A Comparison of Clinical Characteristics in Overweight/Obese and Normal Weight Patients with Psoriasis Vulgaris: A Bicentric Retrospective Observational Study
Li L, Liu K, Duan X, Xu L, Yang Q, Liu F
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1377-1385
Published Date: 30 May 2023
Transcriptome Analysis Identifies Biomarkers for the Diagnosis and Management of Psoriasis Complicated with Depression
Xia X, Yu H, Li Y, Liang Y, Li G, Huang F
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1287-1301
Published Date: 18 May 2023
EDIL3 and VEGF Synergistically Affect Angiogenesis in Endothelial Cells
Niu X, Li X, Feng Z, Han Q, Li J, Liu Y, Zhang K
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1269-1277
Published Date: 18 May 2023
Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
Potestio L, Ruggiero A, Fabbrocini G, Martora F, Megna M
Psoriasis: Targets and Therapy 2023, 13:19-26
Published Date: 4 May 2023
Home Phototherapy Improves Access to Dermatologic Care: A Novel Stakeholder Alliance to Facilitate Its Implementation
Bawany F, Ryan Wolff J, Ritchlin CT, Tausk F
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1175-1180
Published Date: 2 May 2023
JAK Inhibitors as Potential Therapeutic Strategy for the Dilemma of Psoriasis Concurrent with Dermatomyositis in the SARS-CoV-2 Era
Xu Q, Xu N
Clinical, Cosmetic and Investigational Dermatology 2023, 16:1059-1062
Published Date: 20 April 2023
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
Potestio L, Martora F, Fabbrocini G, Battista T, Megna M
Psoriasis: Targets and Therapy 2023, 13:11-18
Published Date: 12 April 2023
Effects of Metabolic Syndrome on Cardiovascular Outcomes of Psoriatic Patients with Coronary Artery Disease: A Single Center Retrospective Cohort Study
Zhao L, Sun L, Yang K, Li Z, Wang Y, Wang T, Wang M, Zeng Y, Zhou X, Yang W
Diabetes, Metabolic Syndrome and Obesity 2023, 16:1003-1012
Published Date: 10 April 2023
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study
Talamonti M, Russo F, Malara G, Hansel K, Papini M, Cattaneo A, Parodi A, Chiricozzi A, Malagoli P, Bardazzi F, Brazzelli V, Dapavo P, Gisondi P, Zane C, Potenza C, Cantoresi F, Fargnoli MC, Trevisini S, Brianti P, Pescitelli L, Gigante G, Bartezaghi M, Caputo L, Aloisi E, Costanzo A
Clinical, Cosmetic and Investigational Dermatology 2023, 16:847-852
Published Date: 1 April 2023
Severe Mental Illness Among Adults with Atopic Eczema or Psoriasis: Population-Based Matched Cohort Studies within UK Primary Care
Adesanya EI, Henderson AD, Matthewman J, Bhate K, Hayes JF, Mulick A, Mathur R, Smith C, Carreira H, Rathod SD, Langan SM, Mansfield KE
Clinical Epidemiology 2023, 15:363-374
Published Date: 17 March 2023
Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study
Matteo M, Battista T, Noto M, Picone V, Fabbrocini G, Ruggiero A, Genco L
Clinical, Cosmetic and Investigational Dermatology 2023, 16:553-564
Published Date: 2 March 2023
Literature Overview of the Relation Between Psoriasis and Alzheimer
Yang Q, Wang J, Mi N, Zou Y
Neuropsychiatric Disease and Treatment 2023, 19:461-468
Published Date: 28 February 2023
The SELP, CD93, IL2RG, and VAV1 Genes Associated with Atherosclerosis May Be Potential Diagnostic Biomarkers for Psoriasis
Liu S, Liu F, Zhang Z, Zhuang Z, Yuan X, Chen Y
Journal of Inflammation Research 2023, 16:827-843
Published Date: 27 February 2023
Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study
Ruggiero A, Fabbrocicni G, Cacciapuoti S, Potestio L, Gallo L, Megna M
Clinical, Cosmetic and Investigational Dermatology 2023, 16:529-536
Published Date: 27 February 2023
Psoriatic Foot Involvement is the Most Significant Contributor to the Inconsistency Between PASI and DLQI: A Retrospective Study from China
Yang J, Hu K, Li X, Hu J, Tan M, Zhang M, Chen J, Kuang Y
Clinical, Cosmetic and Investigational Dermatology 2023, 16:443-451
Published Date: 15 February 2023
Natural Plant Extract – Loganin: A Hypothesis for Psoriasis Treatment Through Inhibiting Oxidative Stress and Equilibrating Immunity via Regulation of Macrophage Polarization
Chen X, Deng Q, Li X, Xian L, Xian D, Zhong J
Clinical, Cosmetic and Investigational Dermatology 2023, 16:407-417
Published Date: 13 February 2023
Elevated C-Reactive Protein and Erythrocyte Sedimentation Rate Correlates with Depression in Psoriasis: A Chinese Cross-Sectional Study
Tan M, Luo Y, Hu J, Hu K, Li X, Yang J, Chen J, Zhu W, Kuang Y
Clinical, Cosmetic and Investigational Dermatology 2023, 16:397-405
Published Date: 13 February 2023
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
Potestio L, Piscitelli I, Fabbrocini G, Martora F, Ruggiero A, Megna M
Clinical, Cosmetic and Investigational Dermatology 2023, 16:369-373
Published Date: 5 February 2023
Risankizumab for the Treatment of Moderate to Severe Psoriasis: Impact on Health-Related Quality of Life and Psychological Wellbeing
Gracia-Cazaña T, Bernal-Masferrer L, Morales-Callaghan AM, Almenara-Blasco M, Gilaberte Y
Clinical, Cosmetic and Investigational Dermatology 2023, 16:221-229
Published Date: 25 January 2023
Interleukin-17A Inhibitor Secukinumab Treatment in HIV-Positive Psoriasis Patient: A Case Report
Gong J, Wu W, Qiu L, Wang X, Bao J, Wang J, Cheng L, Fu Z, Hu F
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2949-2956
Published Date: 30 December 2022
ITGA9 Inhibits Proliferation and Migration of Dermal Microvascular Endothelial Cells in Psoriasis
Hou H, Li J, Wang J, Zhou L, Li J, Liang J, Yin G, Li X, Cheng Y, Zhang K
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2795-2806
Published Date: 20 December 2022
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
Ruggiero A, Martora F, Fabbrocini G, Villani A, Marasca C, Megna M, Fornaro L, Comune R, Potestio L
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2785-2793
Published Date: 19 December 2022
SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab
Yang Q, Xiang T, Wu Y, Ye E, He B, Bu Z
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2547-2554
Published Date: 28 November 2022
Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway
Li L, Lu H, Zhang Y, Li Q, Shi S, Liu Y
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2523-2534
Published Date: 23 November 2022
Single-Cell RNA Sequencing Reveals the Immune Cell Profiling in IMQ Induced Psoriasis-Like Model
Jin S, Wang Y, Qie C, Yang L, Wu Y, Zhang T, Di J, Liu J
Journal of Inflammation Research 2022, 15:5999-6012
Published Date: 28 October 2022
The Anti-Psoriatic Efficacy and Safety Profile of Topical and Intralesional Methotrexate: A Literature Review
Chaiyabutr C, Punnakitikashem P, Silpa-archa N, Wongpraprarut C, Chularojanamontri L
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2253-2274
Published Date: 26 October 2022
Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
Li Y, Lu JJ, Zhong XY, Yu YY, Yu N, Wang Y, Yi XM, Ding YF, Shi YL
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2245-2252
Published Date: 20 October 2022
Rapid Response of Palmoplantar Psoriasis to Risankizumab: A Case Report
Al Muqrin AM, Alghamdi AA, AlShaalan ZM
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2129-2132
Published Date: 4 October 2022
The mRNA Expression Profile of Psoriatic Lesion Distinct from Non-Lesion
Li X, Xing J, Wang F, Li J, Li J, Hou R, Zhang K
Clinical, Cosmetic and Investigational Dermatology 2022, 15:2035-2043
Published Date: 27 September 2022
Psychopathological Symptoms Among Chronically Ill Patients During SARS-CoV-2 Pandemic in Poland
Pawłowski M, Fila-Witecka K, Rymaszewska JE, Kamińska D, Poznański P, Augustyniak-Bartosik H, Zielińska D, Krajewska M, Krajewski PK, Stefaniak A, Szepietowski JC, Pokryszko-Dragan A, Chojdak-Łukasiewicz J, Budrewicz S, Pawłowski T, Szcześniak D, Rymaszewska J
Psychology Research and Behavior Management 2022, 15:2659-2669
Published Date: 16 September 2022
TYK2 in Immune Responses and Treatment of Psoriasis
Shang L, Cao J, Zhao S, Zhang J, He Y
Journal of Inflammation Research 2022, 15:5373-5385
Published Date: 16 September 2022